News & Updates

The risk of open-angle glaucoma (OAG) appears to be aggravated among women with chronic obstructive pulmonary disease (COPD), reports a recent study.

CHK1 inhibition with prexasertib appears to have durable activity in some patients with recurrent ovarian cancer regardless of clinical characteristics, BRCA status, or prior therapies, according to the results of a phase II trial.

There appears to only be a very weak to no significant correlation between hypertension and cognitive function in late life, reports a recent study.

Using the Steno T1 Risk Engines, the dual SGLT*1 and SGLT2 inhibitor sotagliflozin showed potential in reducing the risk of cardiovascular (CV) and renal disease in adults with type 1 diabetes (T1D).

The combination of digital therapeutics (DTx) with the treatment-as-usual (TAU) strategy for essential hypertension is more cost-effective than TAU alone, a recent Japan study has found.